[Hebephrenic schizophrenia].
Umezu H.
Ryoikibetsu Shokogun Shirizu. 2003;(38):38-41.
[Hebephrenic schizophrenia].
Frikha A, Goldberger C.
Encephale. 2005 Oct;31 Pt 2:S27-9.
Hebephrenic schizophrenia.
Hoi HC.
Xianggang Hu Li Za Zhi. 1978 May;(24):21-6.
Heterogeneity of schizophrenia.
Tsuang MT.
Biol Psychiatry. 1975 Aug;10(4):465-74.
Hebephrenic schizophrenia.
Sister MARIE ELISE.
Can Nurse. 1960 Mar;56:248-50.
CNR1, central cannabinoid receptor gene, associated with susceptibility to hebephrenic schizophrenia.
Ujike H, Takaki M, Nakata K, Tanaka Y, Takeda T, Kodama M, Fujiwara Y, Sakai A, Kuroda S.
Mol Psychiatry. 2002;7(5):515-8. doi: 10.1038/sj.mp.4001029.
Paranoid vs hebephrenic schizophrenia: clinical and familial (genetic) heterogeneity.
Winokur G.
Psychopharmacol Commun. 1975;1(6):567-77.
Criteria for subtyping schizophrenia. Clinical differentiation of hebephrenic and paranoid schizophrenia.
Tsuang MT, Winokor G.
Arch Gen Psychiatry. 1974 Jul;31(1):43-7. doi: 10.1001/archpsyc.1974.01760130027004.
The micropsychopathology of hebephrenic/catatonic schizophrenia.
Pfohl B, Winokur G.
J Nerv Ment Dis. 1983 May;171(5):296-300. doi: 10.1097/00005053-198305000-00006.
The core symptoms of schizophrenia.
Flaum M, Schultz SK.
Ann Med. 1996 Dec;28(6):525-31. doi: 10.3109/07853899608999116.
